European Cannabis Company With A £150 Million Price Tag

October 22, 2019

A successful fund-raising round by Emmac Life Sciences has seen it emerge as one of the leading lights of the booming European cannabis industry.

In a press release London-based Emmac Life Sciences says it has raised £15 million in Convertible Loan Notes (CLN) from investors in Europe, North America, Asia and Australia. This follows similar CLN exercises over the last 12 months which have raised £34 million, with the company sating the conversion of these at 50 pence a share equates to a company value of £150 million.

Emmac is a vertically-integrated cannabis business with a strong research focus and such a valuation will make it one of the largest European cannabis businesses.


New Investors On-Board

The previous cash raises have supported the acquisitions of Portuguese cultivation company Terra Verde and U.K. medical laboratory Rokshaw. Antonio Costanzo, CEO of Emmac, said ‘almost two thirds of the funds have come from new institutional investors’. 

“We are not aware of any other UK private medical cannabis company that has raised this quantum of funds…and that it is testament to Emmac’s strategy, strength of management team, and our market leading position,” he added.

The funding round comes just week after Emmac announced a new research partnership with Imperial College London, trialling cannabis-based medicine for the treatment of cancer and acute pain. With NHS clinicians asking for more evidence of the efficacy of cannabis-medicines Emmac hopes its work will go some way to providing that.

More Research Required

Imperial College’s lead researcher consultant Mikael Sodergren, who is also a paid scientific advisor to Emmac Life Sciences, elaborated. He said that while there is ‘undoubted’ evidence that medical cannabis works for certain conditions such as childhood epilepsy there are all sort of claims that are unsubstantiated.

He adds: “As medicinal cannabis has not gone through the normal drug development pathway that the pharma industry and medical profession are used to, we have a lot of work to do to provide robust data to support clinical effectiveness as well as determine efficacy of different constituents of the plant.”

The researchers will also examine whether CBD, one of the main active compounds in cannabis, could help treat cancer. Mr Costanzo said it has a ‘science-led approach and sees Imperial College as the ‘perfect fit’ for this work.

For more stories like this one, please subscribe to the CBD Business Weekly Newsletter.

The post European Cannabis Company With A £150 Million Price Tag appeared first on Cannadelics.





Also in Education

Owning Guns is a Constitutional Right, Unless You’re a Cannabis User

September 28, 2022

Take two of the most hot-button, tendentious issues of our time – cannabis use and gun rights – combine them, and now we really have a debate. As the law currently stands, medical cannabis patients are not afforded their 2nd amendment right to bear arms. Technically, all cannabis consumers are banned from buying guns, but only medical […]

The post Owning Guns is a Constitutional Right, Unless You’re a Cannabis User appeared first on Cannadelics.

Continue Reading

Cannabis policy changes in Africa are welcome. But small producers are the losers

September 28, 2022

TESTSTSARDSAR

Cannabis policy changes in Africa are welcome. But small producers are the losers by Clemence Rusenga

Cannabis is a drug crop with a long history in Africa. Alongside coca and opium poppy, it has been subjected to international control for nearly a century. The International Opium Convention of 1925 institutionalised the international control system and extended the scope of control to cannabis. In 1961 a new international convention was adopted to […]

A link to your site, with your site's name and description as anchor text.

Continue Reading

University of Sydney to Offer Free Cannabis Testing

September 27, 2022

TESTSTSARDSAR

University of Sydney to Offer Free Cannabis Testing by Johnny Green

The University of Sydney is launching a fairly robust study in an attempt to, as the university describes it, “investigate cannabis consumption, behaviours, and attitudes among users.” Part of the study involves offering free, anonymous cannabis testing for people that cultivate their own cannabis in the Australian Capital Territory (ACT). Cannabis was decriminalized in 2020 in the […]

A link to your site, with your site's name and description as anchor text.

Continue Reading